Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market

Key Players

  • Alexion Pharmaceuticals (AstraZeneca)
  • Alnylam Pharmaceuticals
  • Apellis Pharmaceuticals
  • BioCryst Pharmaceuticals
  • Chugai Pharmaceutical (Roche Group)
  • Ionis Pharmaceuticals
  • Novartis AG
  • Omeros Corporation
  • Prestige BioPharma
  • Regeneron Pharmaceuticals
  • Roche
  • Tasly Biopharmaceuticals
  • Teva Pharmaceuticals
Future Market Insights

Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market